These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 8361761)

  • 21. The role of the carboxy terminus of v-Rel in transformation and activation of endogenous gene expression.
    Smardova J; Walker A; Morrison LE; Kabrun N; Enrietto PJ
    Oncogene; 1995 May; 10(10):2017-26. PubMed ID: 7761102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of the v-Rel oncoprotein with cellular transcription factor Sp1.
    Sif S; Gilmore TD
    J Virol; 1994 Nov; 68(11):7131-8. PubMed ID: 7933095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A chicken c-Rel-estrogen receptor chimeric protein shows conditional nuclear localization, DNA binding, transformation and transcriptional activation.
    Zurovec M; Petrenko O; Roll R; Enrietto PJ
    Oncogene; 1998 Jun; 16(24):3133-42. PubMed ID: 9671392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of human immunodeficiency virus 1 gene expression by the src oncoprotein.
    Dehbi M; Beaulieu S; Cohen EA; Bédard PA
    Oncogene; 1994 Aug; 9(8):2399-403. PubMed ID: 8036024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure and autoregulation of the c-rel promoter.
    Hannink M; Temin HM
    Oncogene; 1990 Dec; 5(12):1843-50. PubMed ID: 2284104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cloning and expression of a chicken c-rel cDNA: unlike p59v-rel, p68c-rel is a cytoplasmic protein in chicken embryo fibroblasts.
    Capobianco AJ; Simmons DL; Gilmore TD
    Oncogene; 1990 Mar; 5(3):257-65. PubMed ID: 2179815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Promoter of the human NF-kappa B p50/p105 gene. Regulation by NF-kappa B subunits and by c-REL.
    Cogswell PC; Scheinman RI; Baldwin AS
    J Immunol; 1993 Apr; 150(7):2794-804. PubMed ID: 8454856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of the cyclin D1 and cyclin A1 promoters by B-Myb is mediated by Sp1 binding sites.
    Bartusel T; Schubert S; Klempnauer KH
    Gene; 2005 May; 351():171-80. PubMed ID: 15922873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of v-rel in a replication competent virus: transformation and biochemical characterization.
    Morrison LE; Boehmelt G; Beug H; Enrietto PJ
    Oncogene; 1991 Sep; 6(9):1657-66. PubMed ID: 1656369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. v-Jun downregulates the SPARC target gene by binding to the proximal promoter indirectly through Sp1/3.
    Chamboredon S; Briggs J; Vial E; Hurault J; Galvagni F; Oliviero S; Bos T; Castellazzi M
    Oncogene; 2003 Jun; 22(26):4047-61. PubMed ID: 12821939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. tom-1, a novel v-Myb target gene expressed in AMV- and E26-transformed myelomonocytic cells.
    Burk O; Worpenberg S; Haenig B; Klempnauer KH
    EMBO J; 1997 Mar; 16(6):1371-80. PubMed ID: 9135152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel.
    Gilmore TD
    Oncogene; 1999 Nov; 18(49):6925-37. PubMed ID: 10602467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcriptional activation by human c-myb and v-myb genes.
    Kalkbrenner F; Guehmann S; Moelling K
    Oncogene; 1990 May; 5(5):657-61. PubMed ID: 2189102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A highly conserved cysteine in the v-Myb DNA-binding domain is essential for transformation and transcriptional trans-activation.
    Grässer FA; LaMontagne K; Whittaker L; Stohr S; Lipsick JS
    Oncogene; 1992 May; 7(5):1005-9. PubMed ID: 1570148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitogenesis of quiescent chick fibroblasts by v-Src: dependence on events at the membrane leading to early changes in AP-1.
    Catling AD; Wyke JA; Frame MC
    Oncogene; 1993 Jul; 8(7):1875-86. PubMed ID: 8510932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rel blocks both anti-Fas- and TNF alpha-induced apoptosis and an intact Rel transactivation domain is essential for this effect.
    Zong WX; Bash J; Gélinas C
    Cell Death Differ; 1998 Nov; 5(11):963-72. PubMed ID: 9846183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptional activation of the c-myc gene by the c-myb and B-myb gene products.
    Nakagoshi H; Kanei-Ishii C; Sawazaki T; Mizuguchi G; Ishii S
    Oncogene; 1992 Jun; 7(6):1233-40. PubMed ID: 1594249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutational analysis of v-rel, the oncogene of reticuloendotheliosis virus strain T.
    Bhat GV; Temin HM
    Oncogene; 1990 May; 5(5):625-34. PubMed ID: 2189101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Envelope-dependent transactivation by the retroviral oncoprotein v-Rel is required for efficient malignant transformation of chicken spleen cells.
    Epinat JC; Dvorin EL; Gilmore TD
    Oncogene; 2000 Jun; 19(28):3131-7. PubMed ID: 10918567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The suppression of SH3BGRL is important for v-Rel-mediated transformation.
    Majid SM; Liss AS; You M; Bose HR
    Oncogene; 2006 Feb; 25(5):756-68. PubMed ID: 16186799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.